Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Novel Drug Set to Improve CAR T-Cell Therapy Effectiveness

Sheba and Vidac
CAR T-cell therapy is a revolutionary cancer treatment involving the extraction and genetic modification of a patient's T-cells to produce chimeric antigen receptors (CARs). These engineered T-cells are reintroduced to the patient’s body to attack tumor cells.

While many medical centers around the world depend on external labs to genetically engineer patient T-cells, a process that can take up to a few months and hinder the therapy’s effectiveness, Sheba completes the entire treatment process in less than two weeks thanks to its specialized in-house laboratory. However, not all patients respond to the treatment, with a major hurdle being the Warburg effect, a phenomenon that triggers hyperglycolysis within the tumor microenvironment (TME), which is unfavorable for CAR T-cell therapy effectiveness.

Recently, Sheba and Vidac Pharma partnered to tackle this issue, collaborating on a study that evaluates a novel drug with the potential to reverse the Warburg effect, thereby preventing the lactate-producing hyperglycolysis from compromising treatment efficacy. The new research will be headed by Dr. Elad Jacoby, Head of Pediatric Cell Therapy at Sheba’s Safra Children’s Hospital, and Dr. Yuval Sagiv, CTO of Vidac Pharma. 

This pivotal collaboration marks a significant stride in blood cancer treatment, offering patients across the globe new hope. Stay tuned for updates on the progress of the study.

Sheba Leverages ChatGPT
Accelerating Diagnostics: ChatGPT Results Aligned with Breast Cancer Board Recommendations
Recently, several distinguished Sheba clinicians were impressed by the tool’s capabilities. The group, which included Dr. Vera Sorin, Dr. Eyal Klang, Dr. Miri Sklair-Levy, Prof.…
Read More
Sheba Named Global Oncology Leader
by Newsweek Magazine
Dedicated to providing those in need across the globe ‘Hope Without Boundaries,’ Sheba treats patients from more than 100 countries each year, employing the latest…
Read More
News Sep 10.
A Departure from Hospital-Centric Medicine: The “Care Without an Address” Model
With technological advancements and an aging global population, the world is on the brink of a healthcare transformation. The ‘Care Without an Address’ initiative, spearheaded…
Read More